Floatz logo

HUMAN IMMUNOGLOBULINS

Epilepsy, Cryptogenic

Seoul National University Hospitalother_biologicalPhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

77 Active assets in the Epilepsy, Cryptogenic cohort.

Asset / SponsorPhaseRating
Topamax
SK Life Science, Inc.
Phase 4BBB
Keppra
Beijing Tiantan Hospital
Phase 4BBB
Topamax
Université de Sherbrooke
Phase 4BBB
Eslicarbazepine Acetate
Bial - Portela C S.A.
Phase 4BBB
Lacosamide
Second Affiliated Hospital of Guangzhou Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

HUMAN IMMUNOGLOBULINS is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
70 / 100
View asset →
Post-Polio SyndromeDormant
BB
Indicative ·
67 / 100
View asset →
plasma cell myelomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →